PubMed

Regulatory Considerations for Physiological Closed-Loop Controlled Medical Devices Used for Automated Critical Care: Food and Drug Administration Workshop Discussion Topics.

PMID: 28763355 · 2018

B, a, h, r, a, m, , P, a, r, v, i, n, i, a, n, ;, , C, h, r, i, s, t, o, p, h, e, r, , S, c, u, l, l, y, ;, , H, a, n, n, i, e, b, e, y, , W, i, y, o, r, ;, , A, l, l, i, s, o, n, , K, u, m, a, r, ;, , S, a, n, d, y, , W, e, i, n, i, n, g, e, r

学術誌Anesthesia and analgesia

年2018

PMID28763355

抄録

Part of the mission of the Center for Devices and Radiological Health (CDRH) at the US Food and Drug Administration is to facilitate medical device innovation. Therefore, CDRH plays an important role in helping its stakeholders such as manufacturers, health care professionals, patients, patient advocates, academia, and other government agencies navigate the regulatory landscape for medical devices. This is particularly important for innovative physiological closed-loop controlled (PCLC) devices

公式ソース

PubMedで見る →

データはPubMed / NCBIから取得しています。全文および最新情報は必ず公式記録をご確認ください。